Massachusetts Financial Services’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
KCM
Massachusetts Financial Services's LEGN Position: Q2 2026 in Review
Massachusetts Financial Services reduced its Legend Biotech (LEGN) stake by 0.04% in Q2 2026, selling an estimated $5.75K and leaving 574,685 shares worth $16.6M. The position accounts for 0.01% of the portfolio, ranked #702.
Massachusetts Financial Services first reported a position in LEGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $125M in Q3 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.
- Massachusetts Financial Services held 574,685 shares of Legend Biotech worth $16.6M as of Q2 2026.
- Massachusetts Financial Services sold 213 Legend Biotech shares in Q2 2026, an estimated $5.75K.
- Legend Biotech made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #702 holding.
- Massachusetts Financial Services first reported a position in Legend Biotech in Q4 2022 and has held it in 15 quarters since.
- Massachusetts Financial Services's Legend Biotech position peaked at $125M in Q3 2023.
- 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.
Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.